Sep 21, 2017 10:55 am UTC| Business
ANN ARBOR, Mich., Sept. 21, 2017 -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical and health care solutions company, today announced that it will present at the 2017 Disruptive Growth Company...
Sep 21, 2017 10:50 am UTC| Business
PHILADELPHIA, Sept. 21, 2017 -- Hill International (NYSE:HIL), the global leader in managing construction risk, today announced that the Board of Directors of the Company has determined that the Company will restate the...
ChromaDex to Present at the Ladenburg Thalmann 2017 Healthcare Conference
Sep 21, 2017 10:30 am UTC| Business
IRVINE, Calif., Sept. 21, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of science-based, proprietary health and wellness consumer products and ingredient technologies that promote health longevity announced today...
Sep 21, 2017 10:25 am UTC| Business
Albany - NY, Sept. 21, 2017 -- “Stringent regulations for vehicular emissions to be within permissible limits is primarily driving the demand for aftermarket fuel additives,” says a TMR analyst. Aftermarket fuel...
Global Mycotoxin Binders Market to touch US$387.4 mn by 2025 - TMR
Sep 21, 2017 10:10 am UTC| Business
Albany - NY, Sept. 21, 2017 -- Prominent participants in the global mycotoxin binders market are focusing on augmenting their product portfolios in order to reach out to a wider customer pool. For this, they are...
Chart Completes Acquisition of Hudson Products
Sep 21, 2017 10:00 am UTC| Business
ATLANTA, Sept. 21, 2017 -- Chart Industries, Inc. (“Chart”) (Nasdaq:GTLS) announced that on September 20, 2017 it completed the acquisition of Hudson Products Corporation (“Hudson”) for $410 million in cash from...
BioCryst’s RAPIVAB® (peramivir injection) Receives FDA Approval for a Pediatric Indication
Sep 21, 2017 10:00 am UTC| Business
RESEARCH TRIANGLE PARK, N.C., Sept. 21, 2017 -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) a biotechnology company focused on the development and commercialization of treatments for rare and infectious diseases,...